pandemic infectious disease caused by severe acute respiratory syndrome coronavirus
(SARS-CoV-2). The entry point of SARS-CoV-2 is via angiotensin-converting enzyme 2
(ACE2), which is highly expressed in the alveolar pulmonary cells. Besides, different
peptides and co-mediators such as bradykinin (BK), plasmin, and trans-membrane serine
protease may modulate the affinity and binding of SARS-CoV-2 to ACE2. Therefore, this …